About
Nanoparticle Solutions for Cancer
Areas of Focus
Categories
NanotechDrug Delivery & FormulationBoston & New England
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
465
By Phase
PHASE2: 2PHASE3: 2
By Status
UNKNOWN: 2TERMINATED: 1COMPLETED: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
Today
Hover over trial bars to see details
Recent Trials
NCT02357030Lead Sponsor
Methylphenidate Plus GWI-Nutrient Formula as a Treatment for Patients With Gulf War Illness
PHASE2Unknown
30 participants
Started: Jan 31, 2015 · Completed: May 31, 2016
NCT01966276Lead Sponsor
The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome
PHASE2Unknown
134 participants
Started: Nov 30, 2013 · Completed: Dec 31, 2014
NCT00938236Lead Sponsor
CIS001 Extension Study of Cyclosporine Inhalation Solution
PHASE3Terminated
17 participants
Started: Dec 31, 2009 · Completed: Dec 31, 2011
NCT00755781Lead Sponsor
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
PHASE3Completed
284 participants
Started: Sep 30, 2008 · Completed: Nov 30, 2011
NCT00633373Lead Sponsor
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
N/ANO_LONGER_AVAILABLE
Locations (1)
Headquarters
Watertown, MA, United States
Map
Loading map...